Eden Research Share Discussion Threads

[sortudo7] 14/1/2020 10:36

Despite the disappointing results/share price, I think 2020 will be a promising year ( cedroz/US clearance anytime soon, new territories/label extensions, the huge/trendy/organic market opening up... The share price seems a bargain with all the prospects. Time to top up portfolio?

[brucie5] 14/1/2020 09:48

Yes, I think my 35p YE is almost as unlikely as JAK's 2p. I just didn't want to budge, to allow him room to manoeuvre upwards...
Looks like we're both have egg on face.

[investingisatrickygame] 14/1/2020 08:28

Extremely disappointing results from Eden in today's trading update.

Revenue down 29%
Losses up 180%

Another year in another trading statement confirming that Mevalone cannot be relied upon for revenue with the weather in control of Mevalone sales, not Eden or its sales agents.

Still Eden cannot give a figure for the direct market they are targeting. Very frustrating, what on earth does 'meaningful percentage' mean? Meaningful to who? Why can Eden not simply say, for example, 40% of the market. They know the number, so why can't we?

"The overall global seed treatments market is in excess of $5 billion per year, and the opportunities being pursued by Eden and Corteva represent a meaningful percentage of the overall market and will initially target several major crops, including broad acre crops."

Eden's communications continue to be opaque with shareholders unable to truly understand the value proposition. Eden does not present the value proposition to the market and so how are they to best assess what Eden might be?!

I do hope the full year accounts for 2019 do not show another pay rise for the directors together with more bonuses and share options. They are simply not warranted at this stage and the directors are more than handsomely paid (some would say overpaid) for the results that are being delivered.

They need to focus on shareholder value today. It is no good having a flatline or declining share price in the present (and has been for the last number of years) when the Company has in its armoury, organic status leading to an increased market opportunity and leading sector technology in Sustaine that is microplastics free (very current and very relevant).

Eden continues to use words like significant, but from a shareholder perspective it is anything but.

Eden does not lay out the value proposition and so it is easy to ask the question, "Is an investment Eden and its management worthwhile".

Eden seems to defer the value proposition down the road to "one day Rodney" when they hope to become a significant global player in the biopesticide market. That being the case and looking at history, why don't we all walk away and come back in x number of years?

I'm not actually suggesting we do that, but I do suggest that Eden has a responsibility to properly spell out the current value that sits in Eden and the high growth and innovation forum next month is a window for Eden to correct its appalling narrative.

[brucie5] 14/1/2020 08:26

Pretty dire revenues.

[grahamg8] 14/1/2020 07:33

Must be desperate and reverted to the ''bad growing conditions in Southern Europe'' excuse. From now on whenever results are good it will be because this is a fantastic company, and if bad it will be too wet, dry, hot, cold...

[investingisatrickygame] 13/1/2020 16:15

littlealbatross2

I was so wrong with my 2019 prediction, so who am I to say. But...…….

1) The price predictions made are extremely low to my mind
2) This thinking I believe is justified by what is likely to be delivered by Cedroz through 29 countries, most of which will hopefully be regulator approved and income generating in 2020
3) We must surely get a positive update from Sipcam using Sustaine as we are 2.5 years down the line since their evaluation started and we have had no negative RNS communications on the same. Thus I assume positives, how many of the 19 targets we'll have to wait and see
4) There will of course be Mevalone income
5) There will surely be US approval for Mevalone and Cedroz opening up significant markets and immediate income, Cedroz at least
6)There will likely be an answer from Corteva on their evaluation of Sustaine (as RNS'd) for their seed markets in their 4 territories. A positive here could be significant
7) Allowing for 6 above, one assumes the Americas could be highlighted in the same way this year for someone else or Corteva

Just these alone do not add up in my mind to anything sub 50p.

I don't see how management can not communicate that Eden's share price is woefully low (without hyping the share or setting unreasonable expectations)

I'll be very interested to see how Eden goes about positioning itself at the shares magazine high growth and innovation forum next month, where they must surely put have to put far more emphasis on the share price growth opportunities of Eden and the value that is now at circa 9.5p. You cannot attend an event of that title and subject matter and then underplay your company. To do so would result in a futile attendance and a waste of time for those attending expecting Eden to resonate and communicate in line with the theme of the day.

[littlealbatross2] 12/1/2020 11:32

I suggested we have a bit of fun guessing the end of year share price as we did last year with an initial guess by 31st Jan with a chance to revise that guess by 30 June in light of further news.

So far, end of year guesses are;
Mach100 14.5p post 7308
Jak 2p post 7287
Brucie 35p post 7285
Investing at least 50p+ post 7284
Yourself and Chrischas have offered guesses for end of Jan, or March, or June with conditions eg getting American approval for Cedroz.

I'm going for end of year share price of 17p

Hope you are enjoying life at stud after last year's win.

[northwick] 11/1/2020 16:04

Hello LittlealbertrossI refer you to your post 7281.Have you reached a decision as to what your year end share price target is? Or will you wait for more news before deciding?

[supersonico] 10/1/2020 12:46

Warm Comforting Euphoric... just like good Gravy ..crop protection.

[supersonico] 09/1/2020 16:01

Glyphosate drift reduction and precision slow release granular application with potential for combined Bio/pesticide in single high potency application delivery system for Paddy fields and other such broad acre type places where Drift and toxicity are not cool no more.

[investingisatrickygame] 09/1/2020 15:53

Super

Rice....and?

[investingisatrickygame] 08/1/2020 16:20

As Sean said in his interview or words to this effect, regulation is the path to commerciality.

I would like to see Eden put on the website a simple grid/table format for all relevant products that shows as follows:


E.G.
Product A
Status R&D
Time consideration ongoing
Status Field Trial
Time consideration 24 months
Distribution partner
Territories
Commercial sales 2021
Total market size £1 billion
Milestone Payments Y/N

For every product in their locker. It would show visibility to potential income and keep the investment community better informed.

It can still be a bit cloudy with Eden and uncertainly leads to indecision on this side

[supersonico] 08/1/2020 15:30

Indeed AttyG..Look out for news which mentions drift, granules and something that begins with R.

[attyg] 08/1/2020 15:10

From Investing's link contained in 7311


According to Chemical & Engineering News, BASF, Syngenta, Bayer, Dow and DuPont are competing to fill “the glyphosate gap” – a gap that's growing fast because at least 14 weed species on five continents have developed resistance due to massive applications of glyphosate. As a result, farmers must employ more toxic chemicals to kill the resistant weeds. Commonly known as the “pesticide treadmill,” it's a classic case of chasing a new techno-fix to mop up the mess of an older, failed technology. Agrochemical giants prefer to describe the resistance problem as a business opportunity: In the words of Syngenta's Crop Science CEO, John Atkin: “Resistance is actually quite healthy for our market, because we have to innovate.”

Music to you ears super?

Interesting comments, especially

"because we have to innovate"

[investingisatrickygame] 08/1/2020 14:18

Interview with Proactive

[...]

I'm assuming one year of evaluation then to regulatory approval. Do others agree? First revenue in 2021/2022?


I'd like Eden to lay these things out a little more clearly on the timelines (approximate) and process to income so that new and existing investors understand time to commercialisation.

It doesn't seem to be in Sean's DNA, but staying within stock exchange rules, I'd like to see him tell us how significant these deals are, what they might mean for Eden, how that translates into value, what value might look like, why this differentiates Eden from other players, why Corteva (in this instance) chose Eden, whether this is a step-change/game-changer for Eden and if so why? Just some logical drilling down so that investors can make a better investment decision.

I imagine this deal could be transformational for Eden, but there in no sense of this either in the RNS or on film. Sean's delivery on film is very good and he explains well and in easy to understand terms, but I don't think proactive interviewers 'tee up' the interview to extract the right information for the investment community. They always feel like an update to me, not a reason to buy, which in my book, is what the interview should convey.

The presentation in February hxxps://www.sharesmagazine.co.uk/events/event/growth-innovation-forum-2020-1 is for growth and innovation stocks and Eden is on the agenda.

I quote from the same

"The Growth and Innovation Forum is the UK's only growth and technology focussed investment show.


About the show

Do you want to find the next stock market star performer? ANSWER IS YES

Interested in growth and technology focused companies? ANSWER IS YES

Are you looking to build your wealth through capital growth and income? ANSWER IS YES

and so Eden should play to these questions posed and show the value available through an investment in Eden rather than leaving investors to try and figure out the puzzle. This upcoming event with all the RNS's recently released, really is an opportunity in my book for Eden to sell the investment case to the investor audience which they can do, without giving investment advice.

I hope they do, because our share price is way underperforming the Company's commercial arrangements and the value to be derived from them.

[mirandaj] 08/1/2020 10:26

Andre Negreiros (Corteva) Seed Applied Technologies

[supersonico] 08/1/2020 10:04

Investing,
I would not be surprised given our close relationship with Sumitomo that the USA options will go, like the Corteva deal, to a Sumitomo partner.

I note Sumitomo have plenty of recent experience partnering, some might say Collaborating with Monsanto/Bayer

[supersonico] 08/1/2020 08:29

Corteva Notes. Sumitomo

Corteva (NYSE: CTVA) is the fourth largest agriculture input company in the world and is a publicly traded, pure-play agriculture company. It was created by combining the best of DuPont Crop Protection, DuPont Pioneer seeds and Dow AgroSciences. Pioneer is a global leader in seeds for a wide range of crops.



DuPont and Sumitomo Chemical Company Announce Global Seed-Applied Technology Agreement.
DuPont and Sumitomo Chemical formed this collaboration out of a shared objective to accelerate development and commercialization of novel seed-applied technologies to improve early plant growth and yields. The global agreement leverages the strengths of both companies, combining the conventional chemical and biological pipeline from Sumitomo Chemical, with the advanced seed technology and development and commercialization capability of DuPont Crop Protection, a business unit of DowDuPont Agriculture Division.

[investingisatrickygame] 08/1/2020 08:20

Quite right Super

Look at this

hxxp://www.thedailyrecords.com/2018-2019-2020-2021/world-famous-top-10-list/world/largest-oil-seeds-producing-countries-world-10-top/6855/

Look at America's share of Soybeans - 42%

[supersonico] 08/1/2020 08:02

Well Done Eden, I now look forward to hearing about who has the USA seed treatment trial for Cotton and Soya beans.

[supersonico] 07/1/2020 12:54

Or a tweak or two that once resolved could keep our warehouse fella Busy sending Kits out to all kind of Folk. He may even need a Buddy to share in the euphoria and load a few pallets.
The question is what price euphoria?

Sounds Like / Sounds Good